The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    Synbiotics and the risk of common winter diseases in kids

    Daily supplementation with a synbiotic preparation lowered this risk, according to researchers at Universita di Roma Tor Vergata, in Italy.

    First, the details.

    • 135 young school-age children were assigned to a treatment groups and studied for 3 months during winter.
      • Daily treatment with a synbiotic preparation (Lactobacillus helveticus R0052, Bifidobacterium infantis R0033, Bifidobacterium bifidum R0071, and fructooligosaccharide)
      • Placebo
    • Participants were healthy but had suffered from at least 3 episodes of ear, nose and throat (ENT), respiratory tract, or gastrointestinal illness the previous winter.
    • All health-related events were recorded by parents in a diary and checked by the researchers during monthly visits.
    • The percentage of children free of any episode during the study was recorded.
    • Neither the patients nor researchers knew the treatment given — double blind.

    And, the results.

    • At least 1 illness episode was reported in 32 children in the synbiotic group vs 50 in the placebo group — a significant 25% risk reduction.
    • This difference was due to a significant decrease in the number of children who suffered from at least 1 ENT, respiratory tract or gastrointestinal disorder with the synbiotic vs placebo.
    • At least 1 missed school day due to sickness was noted in 26% of children with the synbiotic vs 43% with placebo — a significant difference.
    • No side effects due to treatment were detected in either group.

    The bottom line?

    “This study suggests,” say the authors, “that a 3-month supplementation with this synbiotic preparation can decrease the risk of occurrence of common infectious diseases in children and limits the risk of school day loss.”

    The results differ from a meta-analysis, which reported that respiratory tract infections do not appear to be influenced by prophylactic administration of probiotics, although probiotics might have a beneficial role in reducing the severity and duration of subsequent respiratory tract infections.

    A primer on pre, pro, and synbiotics is here.

    11/2/10 22:39 JR

    Leave a Comment

    You must be logged in to post a comment.